Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 157

1.

Response to comment on "killer Ig-like receptor 2DL4 does not mediate NK cell IFN-γ responses to soluble HLA-G preparations".

Le Page ME, Goodridge JP, John E, Christiansen FT, Witt CS.

J Immunol. 2014 May 1;192(9):4003-4. doi: 10.4049/jimmunol.1400492. No abstract available.

2.

Modeling the benefits and costs of integrating an acceptable HLA mismatch allocation model for highly sensitized patients.

Nguyen HD, Wong G, Howard K, Claas FH, Craig JC, Fidler S, D'Orsogna L, Chapman JR, Irish A, Ferrari P, Christiansen FT, Lim WH.

Transplantation. 2014 Apr 15;97(7):769-74. doi: 10.1097/01.TP.0000438639.36838.ac.

PMID:
24690676
3.

Killer Ig-like receptor 2DL4 does not mediate NK cell IFN-γ responses to soluble HLA-G preparations.

Le Page ME, Goodridge JP, John E, Christiansen FT, Witt CS.

J Immunol. 2014 Jan 15;192(2):732-40. doi: 10.4049/jimmunol.1301748. Epub 2013 Dec 11.

4.

Peri-operative third party red blood cell transfusion in renal transplantation and the risk of antibody-mediated rejection and graft loss.

Fidler S, Swaminathan R, Lim W, Ferrari P, Witt C, Christiansen FT, D'Orsogna LJ, Irish AB.

Transpl Immunol. 2013 Dec;29(1-4):22-7. doi: 10.1016/j.trim.2013.09.008. Epub 2013 Sep 30.

5.

The influence of non-HLA gene polymorphisms and interactions on disease risk in a Western Australian multiple sclerosis cohort.

Qiu W, Pham K, James I, Nolan D, Castley A, Christiansen FT, Czarniak P, Luo Y, Wu J, Garlepp M, Wilton S, Carroll WM, Mastaglia FL, Kermode AG.

J Neuroimmunol. 2013 Aug 15;261(1-2):92-7. doi: 10.1016/j.jneuroim.2013.04.022. Epub 2013 May 28.

PMID:
23726763
6.

Pre-transplant donor specific anti-HLA antibody is associated with antibody-mediated rejection, progressive graft dysfunction and patient death.

Fidler SJ, Irish AB, Lim W, Ferrari P, Witt CS, Christiansen FT.

Transpl Immunol. 2013 Jun;28(4):148-53. doi: 10.1016/j.trim.2013.05.001. Epub 2013 May 9.

PMID:
23665534
7.

Transnational validation of the Australian algorithm for virtual crossmatch allocation in kidney paired donation.

Böhmig GA, Fidler S, Christiansen FT, Fischer G, Ferrari P.

Hum Immunol. 2013 May;74(5):500-5. doi: 10.1016/j.humimm.2013.01.029. Epub 2013 Feb 1.

PMID:
23380140
8.

High transplant rates of highly sensitized recipients with virtual crossmatching in kidney paired donation.

Ferrari P, Fidler S, Holdsworth R, Woodroffe C, Tassone G, Watson N, Cantwell L, Bennett G, Thornton A, Christiansen FT, D'Orsogna L.

Transplantation. 2012 Oct 15;94(7):744-9. doi: 10.1097/TP.0b013e3182612967.

PMID:
22929595
9.

Contributions of vitamin D response elements and HLA promoters to multiple sclerosis risk.

Nolan D, Castley A, Tschochner M, James I, Qiu W, Sayer D, Christiansen FT, Witt C, Mastaglia F, Carroll W, Kermode A.

Neurology. 2012 Aug 7;79(6):538-46. doi: 10.1212/WNL.0b013e318263c407. Epub 2012 Jul 11.

PMID:
22786591
10.

The detection of NK cell alloreactivity by flow cytometric CD107a assay.

De Santis D, Foley B, Witt CS, Christiansen FT.

Methods Mol Biol. 2012;882:477-89. doi: 10.1007/978-1-61779-842-9_27.

PMID:
22665251
11.

Distinct distribution of killer-cell immunoglobulin-like receptor genes in the Mugil and Ilaita areas of Papua New Guinea.

John E, Christiansen FT, Mueller I, Schofield L, Senitzer D, Siba P, Witt CS.

Tissue Antigens. 2012 Apr;79(4):263-71. doi: 10.1111/j.1399-0039.2012.01848.x. Epub 2012 Feb 9.

PMID:
22320834
12.

Virtual crossmatch approach to maximize matching in paired kidney donation.

Ferrari P, Fidler S, Wright J, Woodroffe C, Slater P, Van Althuis-Jones A, Holdsworth R, Christiansen FT.

Am J Transplant. 2011 Feb;11(2):272-8. doi: 10.1111/j.1600-6143.2010.03313.x. Epub 2010 Nov 10.

13.

Spinal cord involvement in multiple sclerosis: a correlative MRI and high-resolution HLA-DRB1 genotyping study.

Qiu W, Raven S, James I, Luo Y, Wu J, Castley A, Christiansen FT, Carroll WM, Mastaglia FL, Kermode AG.

J Neurol Sci. 2011 Jan 15;300(1-2):114-9. doi: 10.1016/j.jns.2010.09.006.

PMID:
20884011
14.

Clinical profile and HLA-DRB1 genotype of late onset multiple sclerosis in Western Australia.

Qiu W, Wu JS, Castley A, James I, Joseph J, Christiansen FT, Carroll WM, Mastaglia FL, Kermode AG.

J Clin Neurosci. 2010 Aug;17(8):1009-13. doi: 10.1016/j.jocn.2009.12.011. Epub 2010 May 23.

PMID:
20580995
15.

Influence of HLA-DRB1 allele heterogeneity on disease risk and clinical course in a West Australian MS cohort: a high-resolution genotyping study.

Wu JS, James I, Wei Qiu, Castley A, Christiansen FT, Carroll WM, Mastaglia FL, Kermode AG.

Mult Scler. 2010 May;16(5):526-32. doi: 10.1177/1352458510362997. Epub 2010 Mar 5.

PMID:
20207784
16.

HLA-DRB1 allele heterogeneity influences multiple sclerosis severity as well as risk in Western Australia.

Wu JS, James I, Qiu W, Castley A, Christiansen FT, Carroll WM, Mastaglia FL, Kermode AG.

J Neuroimmunol. 2010 Feb 26;219(1-2):109-13. doi: 10.1016/j.jneuroim.2009.11.015. Epub 2009 Dec 16.

PMID:
20006387
17.

Modifying effects of HLA-DRB1 allele interactions on age at onset of multiple sclerosis in Western Australia.

Wu JS, Qiu W, Castley A, James I, Mastaglia FL, Christiansen FT, Carroll WM, Joseph J, Kermode AG.

Mult Scler. 2010 Jan;16(1):15-20. doi: 10.1177/1352458509350312. Epub 2009 Dec 7.

PMID:
19995849
18.

Rapid, flow cytometric assay for NK alloreactivity reveals exceptions to rules governing alloreactivity.

De Santis D, Foley BA, John E, Senitzer D, Christiansen FT, Witt CS.

Biol Blood Marrow Transplant. 2010 Feb;16(2):179-91. doi: 10.1016/j.bbmt.2009.10.026. Epub 2009 Oct 30.

19.

Presence of CSF oligoclonal bands (OCB) is associated with the HLA-DRB1 genotype in a West Australian multiple sclerosis cohort.

Wu JS, Qiu W, Castley A, James I, Joseph J, Christiansen FT, Carroll WM, Mastaglia FL, Kermode AG.

J Neurol Sci. 2010 Jan 15;288(1-2):63-7. doi: 10.1016/j.jns.2009.10.005. Epub 2009 Oct 30.

PMID:
19879597
20.

Allergic women show reduced T helper type 1 alloresponses to fetal human leucocyte antigen mismatch during pregnancy.

Prescott SL, Breckler LA, Witt CS, Smith L, Dunstan JA, Christiansen FT.

Clin Exp Immunol. 2010 Jan;159(1):65-72. doi: 10.1111/j.1365-2249.2009.04042.x. Epub 2009 Oct 23.

21.

Progress in understanding and exploiting the immune response in solid organ and hemopoietic stem cell transplantation.

Christiansen FT, Velardi A.

Curr Opin Immunol. 2009 Oct;21(5):522-4. doi: 10.1016/j.coi.2009.09.001. Epub 2009 Sep 24. No abstract available.

PMID:
19782548
22.

Sporadic inclusion body myositis: HLA-DRB1 allele interactions influence disease risk and clinical phenotype.

Mastaglia FL, Needham M, Scott A, James I, Zilko P, Day T, Kiers L, Corbett A, Witt CS, Allcock R, Laing N, Garlepp M, Christiansen FT.

Neuromuscul Disord. 2009 Nov;19(11):763-5. doi: 10.1016/j.nmd.2009.07.015. Epub 2009 Aug 31.

PMID:
19720533
23.

Natural killer cell allorecognition of missing self in allogeneic hematopoietic transplantation: a tool for immunotherapy of leukemia.

Velardi A, Ruggeri L, Mancusi A, Aversa F, Christiansen FT.

Curr Opin Immunol. 2009 Oct;21(5):525-30. doi: 10.1016/j.coi.2009.07.015. Epub 2009 Aug 28. Review.

PMID:
19717293
24.

Allogeneic hematopoietic stem cell transplantation recipients have defects of both switched and igm memory B cells.

D'Orsogna LJ, Wright MP, Krueger RG, McKinnon EJ, Buffery SI, Witt CS, Staples N, Loh R, Cannell PK, Christiansen FT, French MA.

Biol Blood Marrow Transplant. 2009 Jul;15(7):795-803. doi: 10.1016/j.bbmt.2008.11.024.

25.

Paired kidney donations to expand the living donor pool: the Western Australian experience.

Ferrari P, Woodroffe C, Christiansen FT.

Med J Aust. 2009 Jun 15;190(12):700-3. Review.

PMID:
19527208
26.

The genotype of the NK cell receptor, KIR2DL4, influences INFgamma secretion by decidual natural killer cells.

Goodridge JP, Lathbury LJ, John E, Charles AK, Christiansen FT, Witt CS.

Mol Hum Reprod. 2009 Aug;15(8):489-97. doi: 10.1093/molehr/gap039. Epub 2009 Jun 9.

PMID:
19509110
27.

The reactivity of Bw4+ HLA-B and HLA-A alleles with KIR3DL1: implications for patient and donor suitability for haploidentical stem cell transplantations.

Foley BA, De Santis D, Van Beelen E, Lathbury LJ, Christiansen FT, Witt CS.

Blood. 2008 Jul 15;112(2):435-43. doi: 10.1182/blood-2008-01-132902. Epub 2008 Apr 2.

PMID:
18385451
28.

HLA donor-specific antibody detected by solid phase assay identifies high-risk transplantation pairs irrespective of CDC crossmatch results: case reports and literature review.

D'Orsogna L, Fidler S, Irish A, Saker B, Moody H, Christiansen FT.

Clin Transpl. 2006:497-501. No abstract available.

PMID:
18365410
29.

HLA antibodies and soluble CD30 are associated with poor renal graft outcome: updated results of a single-center cross-sectional study.

Langan LL, D'Orsogna L, Park LP, Hughes TL, Irish A, Luxton G, Witt CS, Christiansen FT.

Clin Transpl. 2006:219-25.

PMID:
18365380
30.

Mapping MHC-resident transplantation determinants.

Malkki M, Gooley TA, Horowitz MM, Absi L, Christiansen FT, Cornelissen JJ, Dormoy A, Dubois V, Gagne K, Gluckman E, Haagenson MD, Oudshoorn M, Spellman S, Petersdorf EW; International Histocompatibility Working Group in Transplantation.

Biol Blood Marrow Transplant. 2007 Aug;13(8):986-95.

31.

14th International HLA and Immunogenetics Workshop: report on KIR receptors and their applications.

Middleton D, Christiansen FT.

Tissue Antigens. 2007 Apr;69 Suppl 1:85-7.

PMID:
17445174
32.

The identification and characterisation of a novel null HLA-DRB1 allele.

Fidler SJ, Smith LK, Christiansen FT.

Tissue Antigens. 2007 Apr;69 Suppl 1:58-60.

PMID:
17445166
33.

Sequencing-based typing identifies novel alleles due to single nucleotide polymorphisms in 'conserved' regions.

Smith LK, Sayer DC, Whidborne RS, Christiansen FT.

Tissue Antigens. 2007 Apr;69 Suppl 1:56-7. Review.

PMID:
17445165
34.

Post-transplant HLA class II antibodies and high soluble CD30 levels are independently associated with poor kidney graft survival.

Langan LL, Park LP, Hughes TL, Irish A, Luxton G, Witt CS, Christiansen FT.

Am J Transplant. 2007 Apr;7(4):847-56.

35.

Three common alleles of KIR2DL4 (CD158d) encode constitutively expressed, inducible and secreted receptors in NK cells.

Goodridge JP, Lathbury LJ, Steiner NK, Shulse CN, Pullikotil P, Seidah NG, Hurley CK, Christiansen FT, Witt CS.

Eur J Immunol. 2007 Jan;37(1):199-211.

36.

MICA, MICB, and MHC beta block matching in bone marrow transplantation: relevance to transplantation outcome.

Kitcharoen K, Witt CS, Romphruk AV, Christiansen FT, Leelayuwat C.

Hum Immunol. 2006 Mar;67(3):238-46. Epub 2006 Mar 29.

PMID:
16698448
38.

Clinical applications of whole-blood PCR with real-time instrumentation.

Castley A, Higgins M, Ivey J, Mamotte C, Sayer DC, Christiansen FT.

Clin Chem. 2005 Nov;51(11):2025-30. Epub 2005 Sep 15.

PMID:
16166168
39.

Killer immunoglobulin-like receptors and HLA act both independently and synergistically to modify HIV disease progression.

Gaudieri S, DeSantis D, McKinnon E, Moore C, Nolan D, Witt CS, Mallal SA, Christiansen FT.

Genes Immun. 2005 Dec;6(8):683-90.

PMID:
16121209
40.

Menopausal hormone therapy and irregular endometrial bleeding: a potential role for uterine natural killer cells?

Hickey M, Crewe J, Goodridge JP, Witt CS, Fraser IS, Doherty D, Christiansen FT, Salamonsen LA.

J Clin Endocrinol Metab. 2005 Oct;90(10):5528-35. Epub 2005 Jul 26.

PMID:
16046584
41.

Natural killer cell HLA-C epitopes and killer cell immunoglobulin-like receptors both influence outcome of mismatched unrelated donor bone marrow transplants.

De Santis D, Bishara A, Witt CS, Nagler A, Brautbar C, Slavin S, Christiansen FT.

Tissue Antigens. 2005 Jun;65(6):519-28.

PMID:
15896199
42.

Use of mRNA- and protein-destabilizing elements to develop a highly responsive reporter system.

Voon DC, Subrata LS, Baltic S, Leu MP, Whiteway JM, Wong A, Knight SA, Christiansen FT, Daly JM.

Nucleic Acids Res. 2005 Feb 16;33(3):e27.

43.

Predisposition to nevirapine hypersensitivity associated with HLA-DRB1*0101 and abrogated by low CD4 T-cell counts.

Martin AM, Nolan D, James I, Cameron P, Keller J, Moore C, Phillips E, Christiansen FT, Mallal S.

AIDS. 2005 Jan 3;19(1):97-9.

PMID:
15627041
44.

Associations between KIR epitope combinations expressed by HLA-B/-C haplotypes found in an HIV-1 infected study population may influence NK mediated immune responses.

Gaudieri S, Nolan D, McKinnon E, Witt CS, Mallal S, Christiansen FT.

Mol Immunol. 2005 Feb;42(4):557-60. Review.

PMID:
15607813
45.

Alleles of the IL12B 3'UTR associate with late onset of type 1 diabetes.

Windsor L, Morahan G, Huang D, McCann V, Jones T, James I, Christiansen FT, Price P.

Hum Immunol. 2004 Dec;65(12):1432-6.

PMID:
15603869
46.

High-Density SNP genotyping defines 17 distinct haplotypes of the TNF block in the Caucasian population: implications for haplotype tagging.

Allcock RJ, Windsor L, Gut IG, Kucharzak R, Sobre L, Lechner D, Garnier JG, Baltic S, Christiansen FT, Price P.

Hum Mutat. 2004 Dec;24(6):517-25.

PMID:
15523649
47.

Assign 2.0: software for the analysis of Phred quality values for quality control of HLA sequencing-based typing.

Sayer DC, Goodridge DM, Christiansen FT.

Tissue Antigens. 2004 Nov;64(5):556-65.

PMID:
15496198
48.

Maternal KIR repertoire is not associated with recurrent spontaneous abortion.

Witt CS, Goodridge J, Gerbase-Delima MG, Daher S, Christiansen FT.

Hum Reprod. 2004 Nov;19(11):2653-7. Epub 2004 Aug 27.

PMID:
15333596
49.

Comparative genomic analysis, diversity and evolution of two KIR haplotypes A and B.

Martin AM, Kulski JK, Gaudieri S, Witt CS, Freitas EM, Trowsdale J, Christiansen FT.

Gene. 2004 Jun 23;335:121-31.

PMID:
15194195
50.

A multicenter international evaluation of single-tube amplification protocols for sequencing-based typing of HLA-DRB1 and HLA-DRB3,4,5.

Sayer DC, Whidborne R, De Santis D, Rozemuller EH, Christiansen FT, Tilanus MG.

Tissue Antigens. 2004 May;63(5):412-23.

PMID:
15104673

Supplemental Content

Loading ...
Support Center